Top 5 Articles for April 2017

April 30, 2017
American Veterinarian Editorial Staff

Did you miss any important news last month? Here are our top 5 most popular articles in April.

Lyme Disease: Experts Weigh in on the Controversies

The number of Lyme disease cases in people in the United States has tripled over the past 20 years. Diagnosis and treatment of Lyme disease remain equally controversial in dogs and people. In this article, infectious disease specialists offer insight and perspective on this confounding disease.

2. Heartworm-Associated Respiratory Disease in Client-Owned Cats

Although cats infected with heartworms are less likely than dogs to develop adult worms, studies have shown that the arrival of immature heartworms at the pulmonary vasculature approximately 70 to 90 days post infection can be associated with severe parenchymal, vascular, and airway disease in cats. Researchers in heartworm-endemic Taiwan tested the correlation between exposure to heartworm and the presence of clinical signs of lower airway/lung disease in some cats.

3. The Cat Friendly Practice Program

The Cat Friendly Practice program began with the recognition that cats and cat owners weren’t coming in to see veterinarians. Elizabeth Colleran, DVM, MS, DABVP (Feline), practice owner of the Cat Hospital of Portland, chair of the Cat Friendly Practice program, explains how the program started and what exactly it does for veterinary practices.

4. Surprise! Cats Actually Like People

If you’re a dog lover, chances are you think cats aren’t very fond of people and would rather be left alone. But a new study from Oregon State University begs to differ. The study found that cats don’t just enjoy spending time with people, they actually prefer it over several other potentially stimulating options.

5. Cell-Penetrating Peptide Targets Senescent Cells to Restore Tissue Function

Researchers designed a cell-penetrating peptide called FOXO4-DRI that selectively targeted senescent cells for apoptosis and restored tissue function. The study makes it possible to envision a point on the horizon where the disease indications are identified that could benefit most from FOXO4-DRI therapy.